<em>The treatment with dornase alfa (Pulmozyme) plays one of the key roles in basic treatment of cystic fibrosis as in children as in adult patients. But effectiveness of this medication depends on different important constituents, starting from its proper administration, to precise execution of intake rules. The article earnestly shows that effectiveness of dornase alfa in many respects depends on proper fulfillment of kinesitherapy. Different rational schemes of drug intake combined with individual types of kinesitherapy exercises were presented.</em><br /><strong><em>Key words: children, cystic fibrosis, dornase alfa, treatment.</em></strong><br /><span style="text-decoration: underline;"><em>(<em><em><em>Voprosy sovremennoi pediatrii — ...
<em>In the past years we have gained enormous success not only in the field of understanding of path...
<em>The article contains the analysis of the role of azithromycin (sumamed) in treatment of respirat...
Background: Dornase alpha improves sputum clearance and pulmonary function in patients with moderate...
<em>Early treatment with Pulmozyme (dornase alfa) and its prolonged use in combination with basis th...
Dornase alpha plays an important role in the basic treatment of cystic fibrosis, having three clinic...
<p><em>The center for diagnostic, treatment, rehabilitation and social adaptation of patients with c...
Chronic diseases of lungs are characterized by the presence of mucostasis which is the reason for of...
The article is devoted to specific disorders of the respiratory system in cystic fibrosis. 64 patien...
OBJECTIVE: To describe the clinical impact of the first year treatment with dornase alfa, according...
<em>The article discusses the problem of basis therapy in patients with chronic Pseudomonas aerugino...
The efficiency of treatment of 12 children with cystic fibrosis using Pulmozyme on a background of s...
In the last years interest has been aroused to pharmacoeconomics — the economic evaluation of treatm...
AbstractDornase alfa has been shown to reduce markers of inflammation and neutrophil-associated meta...
<em>Inhalation therapy has significant place in treatment of different diseases in children. It has ...
<em>Development of new methods of treatment of cystic fibrosis (CF) is necessary because of severe c...
<em>In the past years we have gained enormous success not only in the field of understanding of path...
<em>The article contains the analysis of the role of azithromycin (sumamed) in treatment of respirat...
Background: Dornase alpha improves sputum clearance and pulmonary function in patients with moderate...
<em>Early treatment with Pulmozyme (dornase alfa) and its prolonged use in combination with basis th...
Dornase alpha plays an important role in the basic treatment of cystic fibrosis, having three clinic...
<p><em>The center for diagnostic, treatment, rehabilitation and social adaptation of patients with c...
Chronic diseases of lungs are characterized by the presence of mucostasis which is the reason for of...
The article is devoted to specific disorders of the respiratory system in cystic fibrosis. 64 patien...
OBJECTIVE: To describe the clinical impact of the first year treatment with dornase alfa, according...
<em>The article discusses the problem of basis therapy in patients with chronic Pseudomonas aerugino...
The efficiency of treatment of 12 children with cystic fibrosis using Pulmozyme on a background of s...
In the last years interest has been aroused to pharmacoeconomics — the economic evaluation of treatm...
AbstractDornase alfa has been shown to reduce markers of inflammation and neutrophil-associated meta...
<em>Inhalation therapy has significant place in treatment of different diseases in children. It has ...
<em>Development of new methods of treatment of cystic fibrosis (CF) is necessary because of severe c...
<em>In the past years we have gained enormous success not only in the field of understanding of path...
<em>The article contains the analysis of the role of azithromycin (sumamed) in treatment of respirat...
Background: Dornase alpha improves sputum clearance and pulmonary function in patients with moderate...
Add to ORKG